Illness	Number of cases
Malignant neoplasm of prostate (C61)	159
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	110
Hyperplasia of prostate (N40)	85
Calculus of kidney and ureter - Calculus of ureter (N20.1)	60
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	59
Calculus of kidney and ureter - Calculus of kidney (N20.0)	58
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	50
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2)	40
Malignant neoplasm of kidney except renal pelvis (C64)	38
Obstructive and reflux uropathy (N13.3)	37

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	401
(5-98k.0)	190
Insertion, exchange or removal of a ureteral stent (8-137.00)	172
X-rays of the urinary bladder with contrast medium (3-13f)	152
Computed tomography (CT) of the pelvis without contrast medium (3-206)	144
Computed tomography (CT) of the abdomen without contrast medium (3-207)	139
Insertion, exchange or removal of a ureteral stent (8-137.10)	125
Operation using a surgical robot (5-987.0)	121
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41)	105
Computed tomography of the abdomen with contrast medium (3-225)	102

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	0

External quality assurance according to the DMP

Diabetes mellitus Typ 2

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ05	Weiterführende standortbezogene Informationen unter: www.perinatalzentren.org

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
0	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
0	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
0	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Student training (clinical traineeship / internship year)
Lectureships / teaching posts at colleges and universities
Lectureships / teaching posts at universities of applied sciences
Project-related cooperation with colleges and universities
Editors of scientific journals/textbooks
Doctoral supervision
Participation in multi-centre Phase I/II studies
Participation in multi-centre phase III/IV studies

Training

No.	Training in other healing professions	Comment
HB02	Health and paediatric nurse (m/f)
HB01	Nurse and health care worker (m/f)
HB07	Surgical technical assistant (m/f)
HB15	Anaesthesia technical assistant (m/f)
HB03	Physical therapist / physiotherapist (m/f)
HB05	Medical technical radiology assistant (MTRA) (m/f)
HB18	Emergency paramedics (m/f) (training period 3 years)
HB20	Nursing professional B. Sc.
HB19	Nursing professionals